-+ 0.00%
-+ 0.00%
-+ 0.00%

RECURSION PHARMACEUTICALS INC : LEERINK PARTNERS CUTS TARGET PRICE TO $3 FROM $6

Reuters·05/06/2025 11:24:21

Please log in to view news